Stefan Lange

Author PubWeight™ 57.66‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis 2004 3.55
2 Effects of treatment in women with gestational diabetes mellitus: systematic review and meta-analysis. BMJ 2010 3.48
3 Randomized controlled trials on PET: a systematic review of topics, design, and quality. J Nucl Med 2012 2.04
4 Association of low ankle brachial index with high mortality in primary care. Eur Heart J 2006 1.53
5 No inconsistent trial assessments by NICE and IQWiG: different assessment goals may lead to different assessment results regarding subgroup analyses. J Clin Epidemiol 2010 1.47
6 Permanent interstitial low-dose-rate brachytherapy for patients with localised prostate cancer: a systematic review of randomised and nonrandomised controlled clinical trials. Eur Urol 2011 1.47
7 Effects of a supplementary diet with specially processed cereals in patients with short bowel syndrome. Eur J Gastroenterol Hepatol 2008 1.41
8 Negative pressure wound therapy: a vacuum of evidence? Arch Surg 2008 1.38
9 Acupuncture for tension-type headache: a multicentre, sham-controlled, patient-and observer-blinded, randomised trial. J Headache Pain 2007 1.22
10 Attention should be given to multiplicity issues in systematic reviews. J Clin Epidemiol 2008 1.13
11 [In Process Citation]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2015 1.06
12 Unrelated donor stem cell transplantation in acquired severe aplastic anemia: a systematic review. Haematologica 2009 1.05
13 Reversible switching between p- and n-type conduction in the semiconductor Ag10Te4Br3. Nat Mater 2009 1.03
14 Randomised controlled comparison of the Health Survey Short Form (SF-12) and the Graded Chronic Pain Scale (GCPS) in telephone interviews versus self-administered questionnaires. Are the results equivalent? BMC Med Res Methodol 2007 0.95
15 Disagreement in primary study selection between systematic reviews on negative pressure wound therapy. BMC Med Res Methodol 2008 0.91
16 High-level expression of extracellular lipase Lip2 from Yarrowia lipolytica in Pichia pastoris and its purification and characterization. Protein Expr Purif 2006 0.90
17 Negative pressure wound therapy: potential publication bias caused by lack of access to unpublished study results data. BMC Med Res Methodol 2008 0.89
18 Detection of elafin as a candidate biomarker for ulcerative colitis by whole-genome microarray screening. Inflamm Bowel Dis 2006 0.88
19 Effectiveness of early in comparison to late(r) treatment in children with amblyopia or its risk factors: a systematic review. Ophthalmic Epidemiol 2010 0.87
20 First-line matched related donor hematopoietic stem cell transplantation compared to immunosuppressive therapy in acquired severe aplastic anemia. PLoS One 2011 0.87
21 The peptide AF-16 abolishes sickness and death at experimental encephalitis by reducing increase of intracranial pressure. Brain Res 2008 0.86
22 Cholera toxin induces expression of ion channels and carriers in rat small intestinal mucosa. FEBS Lett 2004 0.86
23 Effectiveness of screening preschool children for amblyopia: a systematic review. BMC Ophthalmol 2009 0.85
24 High prevalence of peripheral arterial disease but low antiplatelet treatment rates in elderly primary care patients with diabetes. Diabetes Care 2003 0.85
25 TNF production in macrophages is genetically determined and regulates inflammatory disease in rats. J Immunol 2010 0.84
26 Diet-induced antisecretory factor prevents intracranial hypertension in a dosage-dependent manner. Br J Nutr 2012 0.84
27 Fluorophor-linked immunosorbent assay: a time- and cost-saving method for the characterization of antibody fragments using a fusion protein of a single-chain antibody fragment and enhanced green fluorescent protein. Anal Biochem 2002 0.82
28 Tranexamic acid, an inhibitor of plasminogen activation, aggravates staphylococcal septic arthritis and sepsis. Scand J Infect Dis 2010 0.82
29 Development of monoclonal antibodies for detection of Antisecretory Factor activity in human plasma. J Immunol Methods 2008 0.82
30 Diagnostic accuracy of vision screening tests for the detection of amblyopia and its risk factors: a systematic review. Graefes Arch Clin Exp Ophthalmol 2009 0.82
31 Recombinant production of human microsomal cytochrome P450 2D6 in the methylotrophic yeast Pichia pastoris. Chembiochem 2005 0.82
32 Relationship between lipid parameters and the presence of peripheral arterial disease in elderly patients. Curr Med Res Opin 2004 0.80
33 By Overexpression in the Yeast Pichia pastoris to Enhanced Enantioselectivity: New Aspects in the Application of Pig Liver Esterase We thank the Konrad-Adenauer foundation (St. Augustin, Germany) for a stipend to A.M., Prof. R. D. Schmid (Institute of Technical Biochemistry, Stuttgart University) for his support and discussions, and A. Gollin for the synthesis of the acetates. Angew Chem Int Ed Engl 2001 0.80
34 The anterior commissure is a pathway for contralateral spread of herpes simplex virus type 1 after olfactory tract infection. J Neurovirol 2015 0.80
35 Cholera toxin induces a transient depletion of CD8+ intraepithelial lymphocytes in the rat small intestine as detected by microarray and immunohistochemistry. Infect Immun 2005 0.80
36 Antisecretory factor modulates GABAergic transmission in the rat hippocampus. Regul Pept 2005 0.79
37 Five mucosal transcripts of interest in ulcerative colitis identified by quantitative real-time PCR: a prospective study. BMC Gastroenterol 2008 0.79
38 Antisecretory factor-induced regression of Crohn's disease in a weak responder to conventional pharmacological treatment. Inflamm Bowel Dis 2003 0.79
39 The peptide AF-16 decreases high interstitial fluid pressure in solid tumors. Acta Oncol 2011 0.79
40 The peptide AF-16 and the AF protein counteract intracranial hypertension. Acta Neurochir Suppl 2012 0.78
41 Reduced incidence of distant metastases and lower mortality in 1072 patients with breast cancer with a history of hormone replacement therapy. Am J Obstet Gynecol 2007 0.78
42 B 221, a medical food containing antisecretory factor reduces child diarrhoea: a placebo controlled trial. Acta Paediatr 2007 0.78
43 Real-time PCR quantification analysis of five mucosal transcripts in patients with Crohn's disease. Eur J Gastroenterol Hepatol 2008 0.78
44 Systematic review of surgical treatments for benign prostatic hyperplasia and presentation of an approach to investigate therapeutic equivalence (non-inferiority). BJU Int 2011 0.78
45 Development and validation of LC/ESI-MS method for the detection and quantification of exogenous ceramide NP in stratum corneum and other layers of the skin. J Pharm Biomed Anal 2011 0.78
46 Specially processed cereals diet increases plasma levels of active antisecretory factor and up-regulates rat hepatic glutathione S-transferase mu. Nutrition 2010 0.77
47 Cutaneous signs of liver disease: value for prognosis of severe fibrosis and cirrhosis. Liver Int 2008 0.77
48 Antisecretory factor-inducing therapy improves the clinical outcome in patients with Ménière's disease. Acta Otolaryngol 2010 0.77
49 Cholera toxin protects against action by Clostridium difficile toxin A. The role of antisecretory factor in intestinal secretion and inflammation in rat. APMIS 2003 0.76
50 Antisecretory factor effectively and safely stops childhood diarrhoea: a placebo-controlled, randomised study. Acta Paediatr 2014 0.76
51 Uptake of the antisecretory factor peptide AF-16 in rat blood and cerebrospinal fluid and effects on elevated intracranial pressure. Acta Neurochir (Wien) 2014 0.76
52 Faecal analysis and plasma complement factor 3c levels at admission for an acute attack of ulcerative colitis are predictive of the need for colectomy. Eur J Gastroenterol Hepatol 2014 0.76
53 Induction and cellular expression of tartrate resistant acid phosphatase during dextran sodium sulphate induced colitis in rats. Histochem Cell Biol 2009 0.75
54 [Procedures and methods of benefit assessments for medicines in Germany - a comment - letter no. 1]. Dtsch Med Wochenschr 2009 0.75
55 Correction: Local Difference Measures between Complex Networks for Dynamical System Model Evaluation. PLoS One 2015 0.75
56 The role of PET and PET-CT scanning in assessing response to neoadjuvant therapy in esophageal carcinoma. Dtsch Arztebl Int 2015 0.75
57 Re: Early identification of language delay by direct language assessment or parent report? J Dev Behav Pediatr 2009 0.75
58 Evidence-based assessment of PET in Germany. J Nucl Med 2012 0.75
59 Unfounded Concerns. Dtsch Arztebl Int 2016 0.75
60 Early assessment of benefits. Dtsch Arztebl Int 2012 0.75
61 Re: Allogeneic stem cell transplantation in acute myeloid leukemia--establishment of indications on the basis of individual risk stratification. Statement was not sufficiently supported. Dtsch Arztebl Int 2009 0.75
62 Molecular characterization of StcI esterase from Aspergillus nidulans. Appl Microbiol Biotechnol 2009 0.75
63 [Large clinical goals in focus]. Z Evid Fortbild Qual Gesundhwes 2010 0.75
64 Antisecretory factor: a clinical innovation in Ménière's disease? Acta Otolaryngol 2003 0.75
65 Population-based screening of children for specific speech and language impairment in Germany: a systematic review. Folia Phoniatr Logop 2011 0.75
66 The Influence of a Novel Dimeric Ceramide Molecule on the Nanostructure and the Thermotropic Phase Behavior of a Stratum Corneum Model Mixture. Langmuir 2017 0.75
67 Response to the expertise: procedures and methods of benefit assessments for medicines in Germany, by Geertruida E. Bekkering and Jos Kleijnen. Eur J Health Econ 2009 0.75
68 Growth and nutrition: the first six months. Nestle Nutr Workshop Ser Pediatr Program 2008 0.75
69 [In cancer things are different and in fact different standards apply]. Z Evid Fortbild Qual Gesundhwes 2013 0.75
70 The Range and Scientific Value of Randomized Trials. Dtsch Arztebl Int 2017 0.75
71 Novel rat models to study primary genital herpes simplex virus-2 infection. Arch Virol 2015 0.75
72 The role of antisecretory factor in pancreatic exocrine secretion: studies in vivo and in vitro. Exp Physiol 2015 0.75
73 [Benefit assessment in special situations--rare diseases]. Z Evid Fortbild Qual Gesundhwes 2008 0.75
74 [Screening for prostate cancer]. Ther Umsch 2013 0.75
75 [Benefit assessment of medical services in German health service - legal framework, historical and international perspective]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2015 0.75